Back to Top
Racotumomab Biosimilar - Research Grade
$710.00 - $6,900.00
Racotumomab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
idiotope of anti-
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Racotumomab is an anti-idiotypic antibody that mimics the NeuGc-GM3 tumor ganglioside, a target in cancer-vaccine and idiotype-network research. This recombinant human IgG1 kappa antibody is an unconjugated, non-therapeutic analog of racotumomab, produced in CHO cells. For research use only, it is formulated to low endotoxin for in vivo suitability and manufactured in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories. It is useful as a defined reagent for anti-idiotype and immune-network studies, functional binding assays, and preclinical tumor-immunology models. Its dependable specifications streamline reagent management in large studies.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












